Antonia D’Errico
University of Bologna
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Antonia D’Errico.
American Journal of Kidney Diseases | 2003
Archil B. Chkhotua; Elena Gabusi; Annalisa Altimari; Antonia D’Errico; Michaela Yakubovich; Joerg Vienken; Sergio Stefoni; Pasquale Chieco; A. Yussim; Walter Franco Grigioni
BACKGROUND The goal of the current study was to examine the potential value of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor (CDKI) genes in the process of human kidney aging in vivo, and in the development of chronic allograft nephropathy (CAN). METHODS Expression of p16(INK4a) and p27(Kip1) CDKI genes was evaluated and compared in 20 normal human kidney tissues of different ages (range, 21 to 80 years) and in 9 chronically rejected kidney grafts. Age dependency of marker expression was analyzed by the Pearson correlation and linear regression. RESULTS Expression of p16 in cortical tubular (CTS) and interstitial (CIS) cells of normal kidney was age dependent (correlation coefficients: 0.608 and 0.726, 95% confidence interval [CI]: 0.227 to 0.828 and 0.417 to 0.884, respectively). Cortical tubular expression of p27 was also correlated with increasing age (0.672, 95% CI: 0.327 to 0.859). Linear regression analyses confirmed the linearity of marker relationship with age (coefficient of determination R(2):0.370, 0.452, and 0.527 for CIS p16, CTS p27, and CTS p16, respectively). The mean chronological and predicted graft ages (53 +/- 21 and 76 +/- 8.9 years, respectively) were significantly different (P = 0.0126). The glomeruli, tubules, and interstitial cells of rejected grafts expressed significantly higher levels of p16 and p27 than normal kidneys. Expression of p16 in glomerular and cortical interstitial cells was higher in grade 3 of CAN than in grade 2 (P = 0.013 and 0.004, respectively). CONCLUSION The results of the current study show that expression of p16(INK4a) and p27(Kip1) CDKI genes is increased in cortical cells of the aging human kidney and in chronic allograft rejection, supporting the senescence theory of CAN.
American Journal of Clinical Pathology | 2004
Alberto Grassi; M. Susca; S. Ferri; Elena Gabusi; Antonia D’Errico; Gabriele Farina; Silvana Maccariello; Daniela Zauli; Francesco B. Bianchi; G. Ballardini
One of the first stages of apoptosis is cytokeratin cleavage mediated by caspases, which is associated with the expression of a neoepitope, the cleavage site of cytokeratin 18, identifiable by the M30 monoclonal antibody. The aim of this study was to evaluate the timing of neoantigen expression and its modifications in the various morphologic stages of apoptosis on frozen and paraffin-embedded sections from liver biopsies of patients with chronic hepatitis or transplanted liver. The appearance of this neoepitope coincides with the gradual disappearance of cytokeratins, with the appearance of nuclear DNA fragmentation, and with the presence of Councilman bodies. The staining patterns on paraffin-embedded sections of liver specimens were similar to those found in frozen sections, with a reduced sensitivity. The M30 antibody is correlated with apoptosis, and its specificity for epithelial cells makes this method the first choice for routine evaluation of apoptosis in liver epithelial cells.
Archive | 1994
Patrizia Paterlini; Karine Poussin; Antonia D’Errico; Stella De Mitri; Michael Kew; Walter Franco Grigioni; Dominique Franco; Christian Bréchot
HBV genomes have been described even in HBsAg-negative patients with hepatocellular carcinoma (HCC), but the role of hepatitis B virus (HBV) in liver transformation is still unclear. We assessed the rate of persistence, the structure, and the RNA expression of HBV genomes in HBsAg-negative HCC using HBV- DNA PCR and HBV-RNA RT-PCR. HBV DNA genomes have been detected in 37 (59%) of 63 HBsAg-negative HCC. Defective genomes have been found more frequently in tumorous than nontumorous tissues (19/29 vs 1/9) and in seronegative than seroconverted patients (9/12 vs 1/7). A significant accumulation of X RNA was shown in 7/9 tumorous and 7/8 nontumorous tissues. By contrast, S and C RNAs were barely expressed in both tumorous and nontumorous tissues. These results suggest a role for the potentially transforming, transactivating X protein in the HBV-related liver carcinogenesis in HBsAg-negative patients.
Pathology Research and Practice | 2010
Gian Luca Grazi; Gaetano Vetrone; Antonia D’Errico; Giacomo Caprara; Giorgio Ercolani; Matteo Cescon; Matteo Ravaioli; Massimo Del Gaudio; Marco Vivarelli; Matteo Zanello; Antonio Daniele Pinna
Malignant mixed tumors of the liver in adults are extremely rare. To our knowledge, only a few cases have been reported in the literature. Nested stromal-epithelial tumors (NSET) of the liver are characterized by non-hepatocytic, non-biliary tumors with nests of epithelial and spindle cells, an associated myofibroblastic stroma, as well as variable calcifications and ossifications. We report a case of NSET of the liver affecting a young woman and provide detailed histological and clinical follow-up data, adding an additional case of this extremely rare pathology to the literature.
Oncotarget | 2018
Francesco Vasuri; Silvia Fittipaldi; Vanessa De Pace; Laura Gramantieri; Valentina Bertuzzo; Matteo Cescon; Antonio Daniele Pinna; Michelangelo Fiorentino; Antonia D’Errico; Matteo Ravaioli
The choice of surgical treatment for hepatocellular carcinoma (HCC) depends on several prognostic variables, among which histological features, like microvascular invasion and tumor grade, are well established. This study aims to identify the tissue miRNAs predictive of recurrence after liver resection in “histologically advanced” HCC. We selected 54 patients: 15 retrospective resected patients without recurrence (group A), 19 retrospective resected patients with HCC recurrence (group B), and 20 prospective patients (group C), with 4 recurrence cases. All selected HCC were “histologically advanced” (high Edmondson grade and/or presence of microvascular invasion). A wide spectrum of miRNAs was studied with TaqMan Human microRNA Arrays; qRT-PCR assays were used to validate results on selected miRNAs; immunohistochemistry for IGF2 was applied to study the mechanism of miR-483-3p. As a result, a significant differential expression between group A and B was found for 255 miRNAs. Among them we selected miR-483-3p and miR-548e (P<0.001). As a single variable (group C), HCC with miR-483-3p downregulation (mean fold increase 0.21) had 44.4% of recurrence cases; HCC with miR-483-3p upregulation (mean fold increase 5.94) showed no recurrence cases (P=0.011). At immunohistochemistry (group C), the HCC with loss of cytoplasmic IGF2 expression showed a down-regulation of miR-483-3p (fold increase 0.57). In conclusion, in patients with “histologically advanced” HCC, the analysis of specific tissue miRNAs (particularly miR-483-3p) could help identify the recurrence risk and choose which treatment algorithm to implement (follow-up, resection or transplantation). This could have an important impact on patient survival and transplantation outcome, improving organ allocation.
Digestive Diseases and Sciences | 2017
Silvia Fittipaldi; Francesco Vasuri; Sonia Bonora; Alessio Degiovanni; Giacomo Santandrea; Alessandro Cucchetti; Laura Gramantieri; Luigi Bolondi; Antonia D’Errico
BackgroundmiRNA deregulation and vascular modifications constitute promising predictors in the study of hepatocellular carcinoma (HCC). In the literature, the relative miRNA abundance in HCC is usually determined using as control non-matched tumoral tissue, healthy liver, or cirrhotic liver. However, a common standard RNA control for the normalization toward the tissue gene expression was not settled yet.AimTo assess the differences existing in the quantitative miRNA gene expression in HCC on tissue according to two different liver controls.MethodsA wide array of miRNAs was analyzed on 22 HCCs arisen in cirrhotic and non-cirrhotic livers by means of microfluidic cards. Control samples included total RNA extracted from healthy and cirrhotic livers. Immunohistochemistry for CD34 and Nestin was performed to assess the pattern of intratumoral vascular modifications.ResultsSix miRNAs were deregulated in HCCs using either controls: miR-532, miR-34a, miR-93, miR-149#, miR-7f-2#, and miR-30a-5p. Notably, the miRNA expression changed significantly between HCCs arisen in cirrhotic and non-cirrhotic livers, according to the control used for normalization. Different miRNA profiles were found also in HCCs with different vascular patterns, according to the control used for normalization.ConclusionsOur data confirm that the choice of the methodology, and particularly the control used for normalization, represents the main concern in miRNA evaluation, particularly in a heterogeneous model such as liver pathology. Still we observed the deregulation of some common miRNAs as promising in HCC cancerogenesis and progression. A standardized control will be a crucial achievement to compare miRNA expression among different laboratories.
World Journal of Gastroenterology | 2018
Francesco Vasuri; Michela Visani; Giorgia Acquaviva; Thomas Brand; Michelangelo Fiorentino; Annalisa Pession; Giovanni Tallini; Antonia D’Errico; Dario de Biase
Hepatocellular carcinoma (HCC) is the most common primary liver malignant neoplasia. HCC is characterized by a poor prognosis. The need to find new molecular markers for its diagnosis and prognosis has led to a progressive increase in the number of scientific studies on this topic. MicroRNAs (miRNAs) are small non-coding RNA that play a role in almost all main cellular pathways. miRNAs are involved in the regulation of expression of the major tumor-related genes in carcinogenesis, acting as oncogenes or tumor suppressor genes. The aim of this review was to identify papers published in 2017 investigating the role of miRNAs in HCC tumorigenesis. miRNAs were classified according to their role in the main molecular pathways involved in HCC tumorigenesis: (1) mTOR; (2) Wnt; (3) JAK/STAT; (4) apoptosis; and (5) MAPK. The role of miRNAs in prognosis/response prediction was taken into consideration. Bearing in mind that the analysis of miRNAs in serum and other body fluids would be crucial for clinical management, the role of circulating miRNAs in HCC patients was also investigated. The most represented miRNA-regulated pathway in HCC is mTOR, but apoptosis, Wnt, JAK/STAT or MAPK pathways are also influenced by miRNA expression levels. These miRNAs could thus be used in clinical practice as diagnostic, prognostic or therapeutic targets for HCC treatment.
PLOS ONE | 2018
Roberta Budriesi; Fabio Vivarelli; Donatella Canistro; Rita Aldini; Clara Babot Marquillas; Ivan Corazza; Romana Fato; Silvia Cirillo; Antonia D’Errico; Cristiano Bolchi; Monica Cevenini; Alessio Degiovanni; Maria Frosini; Luca Camarda; Alberto Chiarini; Matteo Micucci
The effects of Castanea sativa Mill. have been studied in high fat diet (HFD) overweight rats. Natural Extract of Chestnut bark (Castanea sativa Mill.) (ENC®), rich in ellagitannins, has been studied in 120 male Sprague-Dawley rats, divided in four groups. Two groups were controls: regular (RD) and HDF diet. Two groups received ENC® (20 mg/kg/day): RD + ENC® and HFD + ENC®. At baseline and at 7, 14 and 21 days, weight gain, serum lipids, plasma cytokines, liver histology, microsomial enzymes and oxidation, intestinal oxidative stress and contractility were studied. HFD increased body weight, increased pro-inflammatory cytokines, induced hepatocytes microvescicular steatosis, altered microsomial, increased liver and intestinal oxidative stress, deranged intestinal contractility. In HFD-fed rats, ENC® exerted antiadipose and antioxidative activities and normalized intestinal contractility, suggesting a potential approach to overweight management associated diseases.
BMC Cancer | 2018
Federica Isidori; Deborah Malvi; Silvia Fittipaldi; Claudio Forcato; Isotta Bozzarelli; Claudia Sala; Giovanni Raulli; Antonia D’Errico; Michelangelo Fiorentino; Marco Seri; Kausilia K. Krishnadath; Elena Bonora; Sandro Mattioli
BackgroundWe report on a female patient who underwent primary radical resection for a stage 2B Her-2-positive Barrett’s-type esophageal adenocarcinoma (EAC). Despite Her-2 targeted therapy, her disease recurred and required repeated metastectomies.Case presentationDigital cell sorting and targeted sequencing of cancer sub-clones from EAC and metastases revealed a completely mutated TP53, whereas the sorted stromal cells were wild-type. Her-2 amplification was significantly lower in the metastases when the patient became therapy-resistant.ConclusionsThe mechanism of therapy resistance illustrated by this case could only be detected through accurate analysis of tumor sub-populations.Investigating tumor sub-populations of recurrent disease is important for adjusting therapy in recurrent EAC.
Archive | 2015
Antonia D’Errico; Deborah Malvi; Francesco Vasuri
Safety during organ recruitment means donor safety and organ safety. Efforts to advance transplant safety are ongoing and include improvements to screening tests and checks to detect any kind of donor disease and ensure good graft function after transplantation.